SGEN » Topics » Condensed Consolidated Balance Sheets

This excerpt taken from the SGEN 8-K filed Oct 22, 2009.

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands)

 

     September 30,
2009
   December 31,
2008

Assets

     

Cash, cash equivalents, short and long term investments

   $ 306,016    $ 160,708

Other assets

     20,405      27,009
             

Total assets

   $ 326,421    $ 187,717
             
Liabilities and Stockholders’ Equity      

Accounts payable and accrued liabilities

   $ 21,946    $ 15,879

Deferred revenue and long-term liabilities

     88,928      92,820

Stockholders’ equity

     215,547      79,018
             

Total liabilities and stockholders’ equity

   $ 326,421    $ 187,717
             


This excerpt taken from the SGEN 8-K filed Jul 23, 2009.

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands)

 

     June 30,
2009
   December 31,
2008

Assets

     

Cash, cash equivalents, short and long term investments

   $ 189,937    $ 160,708

Other assets

     22,884      27,009
             

Total assets

   $ 212,821    $ 187,717
             

Liabilities and Stockholders’ Equity

     

Accounts payable and accrued liabilities

   $ 19,159    $ 15,879

Deferred revenue and long-term liabilities

     93,572      92,820

Stockholders’ equity

     100,090      79,018
             

Total liabilities and stockholders’ equity

   $ 212,821    $ 187,717
             


This excerpt taken from the SGEN 8-K filed Apr 23, 2009.

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands)

 

      March 31,
2009
   December 31,
2008

Assets

     

Cash, cash equivalents, short and long term investments

   $ 192,413    $ 160,708

Other assets

     28,527      27,009
             

Total assets

   $ 220,940    $ 187,717
             

Liabilities and Stockholders’ Equity

     

Accounts payable and accrued liabilities

   $ 17,588    $ 15,879

Deferred revenue and long-term liabilities

     95,861      92,820

Stockholders’ equity

     107,491      79,018
             

Total liabilities and stockholders’ equity

   $ 220,940    $ 187,717
             


This excerpt taken from the SGEN 8-K filed Feb 5, 2009.

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands)

 

     December 31,
     2008    2007

Assets

     

Current assets

     

Cash, cash equivalents and short-term investments

   $ 95,179    $ 111,361

Other current assets

     15,537      7,990
             

Total current assets

     110,716      119,351

Property and equipment, net

     10,996      10,294

Long-term investments

     65,529      18,223

Other non-current assets

     476      662
             

Total assets

   $ 187,717    $ 148,530
             

Liabilities and Stockholders’ Equity

     

Accounts payable and accrued liabilities

   $ 15,879    $ 10,475

Deferred revenue

     24,341      18,873
             

Total current liabilities

     40,220      29,348
             

Deferred revenue, net of current portion

     66,958      64,786

Deferred rent and other long term liabilities

     1,521      410
             

Total long-term liabilities

     68,479      65,196
             

Stockholders’ equity

     79,018      53,986
             

Total liabilities and stockholders’ equity

   $ 187,717    $ 148,530
             

Summary Balance Sheet Information:

     

Cash, cash equivalents and investment securities

   $ 160,708    $ 129,584

Working Capital

   $ 70,496    $ 90,003


This excerpt taken from the SGEN 8-K filed Oct 23, 2008.

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands)

 

     September 30,
2008
   December 31,
2007

Assets

     

Current assets

     

Cash, cash equivalents and short-term investments

   $ 104,526    $ 111,361

Other current assets

     15,417      7,990
             

Total current assets

     119,943      119,351

Property and equipment, net

     11,013      10,294

Long-term investments

     82,568      18,223

Other non-current assets

     476      662
             

Total assets

   $ 214,000    $ 148,530
             

Liabilities and Stockholders’ Equity

     

Accounts payable and accrued liabilities

   $ 14,917    $ 10,475

Deferred revenue

     23,126      18,873
             

Total current liabilities

     38,043      29,348
             

Deferred revenue, net of current portion

     68,771      64,786

Deferred rent and other long-term liabilities

     1,378      410
             

Total long-term liabilities

     70,149      65,196
             

Stockholders’ equity

     105,808      53,986
             

Total liabilities and stockholders’ equity

   $ 214,000    $ 148,530
             

Summary Balance Sheet Information:

     

Cash, cash equivalents and investment securities

   $ 187,094    $ 129,584

Working Capital

   $ 81,900    $ 90,003

 


This excerpt taken from the SGEN 8-K filed Jul 22, 2008.

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands)

 

     June 30,
2008
   December 31,
2007

Assets

     

Current assets

     

Cash, cash equivalents and short-term investments

   $ 113,511    $ 111,361

Other current assets

     16,475      7,990
             

Total current assets

     129,986      119,351

Property and equipment, net

     10,674      10,294

Long-term investments

     84,348      18,223

Other non-current assets

     667      662
             

Total assets

   $ 225,675    $ 148,530
             

Liabilities and Stockholders’ Equity

     

Accounts payable and accrued liabilities

   $ 11,150    $ 10,475

Deferred revenue

     21,312      18,873
             

Total current liabilities

     32,462      29,348
             

Deferred revenue, net of current portion

     67,882      64,786

Deferred rent and other long-term liabilities

     1,210      410
             

Total long-term liabilities

     69,092      65,196
             

Stockholders’ equity

     124,121      53,986
             

Total liabilities and stockholders’ equity

   $ 225,675    $ 148,530
             

Summary Balance Sheet Information:

     

Cash, cash equivalents and investment securities

   $ 197,859    $ 129,584

Working Capital

   $ 97,524    $ 90,003


This excerpt taken from the SGEN 8-K filed Apr 24, 2008.

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands)

 

     March 31,
2008
   December 31,
2007

Assets

     

Current assets

     

Cash, cash equivalents and short-term investments

   $ 167,419    $ 111,361

Other current assets

     10,324      7,990
             

Total current assets

     177,743      119,351

Property and equipment, net

     10,368      10,294

Long-term investments

     48,638      18,223

Other non-current assets

     665      662
             

Total assets

   $ 237,414    $ 148,530
             

Liabilities and Stockholders’ Equity

     

Accounts payable and accrued liabilities

   $ 9,807    $ 10,475

Deferred revenue

     20,291      18,873
             

Total current liabilities

     30,098      29,348
             

Deferred revenue, net of current portion

     67,865      64,786

Deferred rent and other long-term liabilities

     1,389      410
             

Total long-term liabilities

     69,254      65,196
             

Stockholders’ equity

     138,062      53,986
             

Total liabilities and stockholders’ equity

   $ 237,414    $ 148,530
             


This excerpt taken from the SGEN 8-K filed Feb 7, 2008.

Condensed Consolidated Balance Sheets

(Unaudited)

(In thousands)

 

     December 31,
     2007    2006

Assets

     

Current assets

     

Cash, cash equivalents and short-term investments

   $ 111,361    $ 82,587

Other current assets

     7,990      2,842
             

Total current assets

     119,351      85,429

Property and equipment, net

     10,294      7,794

Long-term investments

     18,223      3,986

Other non-current assets

     662      486
             

Total assets

   $ 148,530    $ 97,695
             

Liabilities and Stockholders’ Equity

     

Accounts payable and accrued liabilities

   $ 10,475    $ 5,389

Deferred revenue

     18,873      3,160
             

Total current liabilities

     29,348      8,549
             

Deferred rent, net of current portion

     410      513

Deferred revenue, net of current portion

     64,786      399
             

Total long-term liabilities

     65,196      912
             

Stockholders’ equity

     53,986      88,234
             

Total liabilities and stockholders’ equity

   $ 148,530    $ 97,695
             

"Condensed Consolidated Balance Sheets" elsewhere:

Biota Pharmaceuticals, Inc. (NABI)
Vanda Pharmaceuticals (VNDA)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki